Candel Therapeutics Inc (CADL NASDAQ) stock market data APIs
$5.1174
-0.31(-6.1%)
as of March 9, 2026
Try our APIs with
free plan!
Candel Therapeutics Inc Financial Data Overview
Price chart is built with
Anychart
Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, develops immunotherapies for the cancer patients. It develops CAN-2409, which is in Phase III clinical trials for the treatment of prostate cancer; Phase II clinical trials for the treatment of pancreatic cancer; and Phase II clinical trials for the treatment of non-small cell lung cancer (NSCLC). The company is also developing CAN-3110, which is in Phase Ib clinical trials for the treatment of recurrent high-grade glioma. In addition, it develops the enLIGHTEN Discovery Platform, a systematic, iterative herpes simplex virus based discovery platform leveraging human biology and advanced analytics to create new viral immunotherapy candidates for solid tumors. The company was formerly known as Advantagene, Inc. and changed its name to Candel Therapeutics, Inc. in November 2020. Candel Therapeutics, Inc. was incorporated in 2003 and is headquartered in Needham, Massachusetts.
Prev. Close
5.1174
Open
4.809
High
5.1619
Low
4.7988
52 wk Range
4.25-9.08
Market Cap
362 M
Shares Outstanding
73 247 K
Revenue
31 000
EPS
-0.21
Beta
-0.901
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Candel Therapeutics Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Candel Therapeutics Inc data using free add-ons & libraries
Get Candel Therapeutics Inc Fundamental Data
Candel Therapeutics Inc Fundamental data includes:
- Net Revenue: 31 000
- EBITDA: -38 904 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-13
- EPS/Forecast: -0.18
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Candel Therapeutics Inc News
New
Candel Therapeutics prices $100M public offering
Candel Therapeutics prices $100M public offering Proactive uses images sourced from Shutterstock Candel Therapeutics Inc (NASDAQ:CADL) told investors on Thursday it has priced its previously disclose...
Candel Therapeutics Prices $100 Mln Shares Offering At $5.45/shr To Advance Aglatimagene;Stock Down
(RTTNews) - Candel Therapeutics, Inc. (CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies, announced the pricing of 18.35 million common sha...
Candel Therapeutics Announces Pricing of Public Offering
NEEDHAM, Mass., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biolog...
Candel Therapeutics launches $100M public stock offering; shares down
* Candel Therapeutics (CADL [https://seekingalpha.com/symbol/CADL]) announced [https://seekingalpha.com/pr/20406758-candel-therapeutics-announces-proposed-100-million-public-offering] an underwritte...
Get Candel Therapeutics Inc fresh news feed via Financial News API
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
